Female Hair Loss: Causes, Types & Best Treatment Options

Why Women Lose Hair Differently Than Men

Male hair loss follows a predictable pattern — the hairline recedes, then a crown bald spot develops. Female hair loss is subtler, more diffuse, and more varied. Women typically retain their frontal hairline but notice overall thinning, a widening center part, or reduced ponytail thickness. This makes it easy to dismiss until significant loss has already occurred.

Female hair loss also has more varied root causes than male pattern baldness. Understanding which type you have — or whether multiple causes are contributing — is essential before starting treatment.

The Three Most Common Types of Female Hair Loss

1. Female Pattern Hair Loss (FPHL / Androgenetic Alopecia)

Female pattern hair loss (FPHL) is the most common form, affecting up to 40% of women by age 50. It's driven by a sensitivity to androgens (specifically DHT, dihydrotestosterone) in the hair follicles, which causes them to miniaturize over time. Follicles don't disappear — they shrink, producing thinner and shorter hairs until they eventually stop producing visible hair altogether.

How it presents: Gradual thinning on the crown and top of the scalp. The part widens. Ponytails get thinner. Frontal hairline is usually preserved. Often worsens at menopause when estrogen drops and the androgen-to-estrogen ratio shifts.

Key risk factors: Family history (maternal or paternal), PCOS, menopause, hormonal contraceptive changes, elevated androgens.

2. Telogen Effluvium

Telogen effluvium (TE) is a temporary but alarming form of hair loss triggered by a physical or emotional "shock" to the body. Normally, about 10–15% of hairs are in the resting (telogen) phase at any given time. After a significant stressor, up to 70% of hairs can prematurely enter the telogen phase and shed 2–4 months later.

Common triggers:

• Childbirth (postpartum hair loss)
• Rapid weight loss or calorie restriction (including GLP-1 medications)
• Severe illness, surgery, or high fever
• Iron deficiency or significant nutritional deficiencies
• Thyroid disorders (both hypo and hyperthyroidism)
• Extreme psychological stress
• Stopping hormonal contraceptives

How it presents: Diffuse shedding all over the scalp, often dramatic handfuls in the shower. Usually peaks at 3–4 months after the trigger and resolves on its own within 6–9 months if the underlying cause is addressed.

3. PCOS-Related Hair Loss

Polycystic ovary syndrome (PCOS) causes elevated androgens — particularly testosterone and DHEA-S — which trigger the same follicle-miniaturization process as FPHL but in women who may be younger and have other PCOS symptoms (irregular periods, acne, hirsutism). PCOS hair loss often looks like FPHL but is driven by active hormonal imbalance rather than genetic predisposition alone.

Distinguishing signs: Hair loss accompanied by acne, irregular periods, excess facial or body hair, difficulty losing weight, or insulin resistance.

Other Causes to Rule Out

Before treating hair loss, it's worth ruling out these correctable underlying causes:

• Thyroid dysfunction: Both hypothyroidism and hyperthyroidism can cause diffuse hair shedding. A TSH test is essential.
• Iron deficiency: Ferritin below 40 ng/mL is associated with hair loss in women, even without anemia. This is extremely common.
• Vitamin D deficiency: Low vitamin D is linked to alopecia areata and may contribute to diffuse shedding.
• Zinc deficiency: Often seen in women on very low-calorie diets or with gut absorption issues.
• Protein deficiency: Hair is primarily protein (keratin). Inadequate protein intake directly impairs hair growth.
• Alopecia areata: An autoimmune condition causing patchy circular hair loss — different from FPHL or TE and requires different treatment.

Treatment Options That Actually Work

Minoxidil for Women

Minoxidil is the only FDA-approved topical treatment for female pattern hair loss. It was originally developed as a blood pressure medication, but its hair-regrowth side effect was quickly recognized and leveraged. It works by prolonging the growth phase of hair follicles and increasing follicle size.

Formulations:

• 2% topical solution: FDA-approved for women; effective but requires twice-daily application.
• 5% topical foam or solution: Higher concentration; once-daily use has similar efficacy to twice-daily 2% and is more convenient. Often prescribed off-label for women.
• Oral minoxidil (low-dose): 0.25–1.25 mg daily (off-label). Growing evidence shows oral minoxidil at very low doses is highly effective for women and avoids scalp irritation. Main side effects: potential facial hair growth at higher doses, rare fluid retention.

What to expect: Initial shedding in the first 2–6 weeks (follicles cycling into growth phase — this is a good sign). Visible improvement at 3–6 months. Maximum results at 12 months. Must be continued indefinitely — hair loss returns after stopping.

Spironolactone

Spironolactone is an aldosterone antagonist that also blocks androgen receptors and reduces androgen production. It's been used off-label for decades for FPHL, PCOS hair loss, and hormonally-driven acne in women. Studies show meaningful improvement in hair density and reduced shedding.

Typical dose: 50–200 mg daily. Starting low (25–50 mg) and titrating up helps minimize side effects.

Who benefits most: Women with FPHL, PCOS-related hair loss, or elevated androgens. Less effective for telogen effluvium.

Side effects: Irregular menstrual cycles (especially early on), breast tenderness, frequent urination, rare elevated potassium. Not for use during pregnancy — teratogenic to male fetuses.

Combination therapy: Minoxidil + spironolactone is a well-established combination that addresses both the follicle-growth side and the androgen-driven miniaturization side. Many providers consider this the gold standard for FPHL in women.

Addressing Nutritional Deficiencies

No topical or oral medication will work optimally if underlying nutritional deficiencies aren't corrected first. Key labs to check:

• Ferritin: Aim for 70–100 ng/mL for hair health (not just above-deficiency range). Iron supplementation if low.
• Vitamin D: Optimal 40–60 ng/mL. Supplement with D3 + K2.
• Thyroid panel: TSH, free T3, free T4.
• Zinc: Supplement if deficient, but avoid excess — high zinc can cause copper deficiency and paradoxically worsen hair.
• Biotin: Biotin deficiency is rare but biotin supplementation is widely used. Evidence for hair benefit is modest unless actually deficient. High-dose biotin can interfere with thyroid lab tests — always disclose to your provider.
• Protein: Increase dietary protein to at least 1g per pound of body weight, focusing on complete proteins.

Hormonal Optimization

For perimenopausal and postmenopausal women, declining estrogen shifts the androgen-to-estrogen ratio and accelerates FPHL. Hormone replacement therapy (HRT) — particularly estradiol — can slow or stabilize hair loss by restoring this balance. This decision involves weighing overall HRT candidacy beyond just hair concerns, but it's a relevant consideration for women experiencing hair loss alongside other menopause symptoms.

Low-Level Laser Therapy (LLLT)

FDA-cleared devices (helmets, combs, caps) that use low-level laser or LED light to stimulate follicle activity. Evidence is moderate — some women see meaningful improvement, others do not. Best used as an adjunct to minoxidil or other treatments rather than standalone. Requires consistent use (2–3x per week or daily depending on device).

Platelet-Rich Plasma (PRP)

PRP injections into the scalp use growth factors from your own blood to stimulate follicle activity. In-office procedure requiring 3 initial treatments, then maintenance every 6–12 months. Evidence is promising for FPHL and TE. More expensive than topical/oral options but can be a useful addition to the toolkit.

What Doesn't Work (or Lacks Evidence)

• Biotin supplements alone: Effective only for true biotin deficiency, which is rare. Won't help otherwise.
• Most "hair growth" shampoos: Ketoconazole shampoo has some evidence as an adjunct. Most others are marketing, not medicine.
• Castor oil, rosemary oil: Some preliminary evidence for rosemary oil approaching minoxidil efficacy in one small study, but evidence is thin. Not harmful — can try as adjunct.
• DHT-blocking supplements (saw palmetto): Weak evidence, inconsistent results. Less effective than spironolactone for androgen-driven loss.

Building Your Treatment Plan

Effective treatment starts with accurate diagnosis. A provider should evaluate your hair loss pattern, review bloodwork (thyroid, ferritin, androgens), consider your hormonal status, and identify any triggers before recommending a treatment protocol.

At Truventa Medical, our providers assess all of these factors and create personalized plans that may include minoxidil, spironolactone, nutritional optimization, or hormonal support — based on your specific situation.